TY - JOUR
T1 - Ventricular Capture Management™ in pediatric pacing
T2 - Efficacy and safety
AU - Silvetti, Massimo S.
AU - De Santis, Antonella
AU - Grutter, Giorgia
AU - Di Ciommo, Vincenzo
AU - Drago, Fabrizio
PY - 2005/9
Y1 - 2005/9
N2 - Background: The Ventricular Capture ManagementTM (VCM) of Medtronic Kappa 700 series pacemakers (PM) performs automatic threshold detection and optimization of pacing output that may enhance generator longevity. We evaluated efficacy and safety of this algorithm in children. Methods. The study was prospective, non-randomized, involving 50 consecutive patients (mean age 5.6 ± 6.6 years, median 4 years), enrolled at first PM implant. VCM was active from the implant, with nominal values of safety margin, minimum adapted pulse amplitude and width. Leads were endocardial and epicardial, all unipolar. Thresholds and pacing outputs were registered with telemetric PM interrogation. Endocardial and epicardial thresholds and outputs were also compared. Follow-up duration was 27 ± 13 months (range 6-49 months). Results: A significant reduction in pulse amplitude was evident since the sixth month. Thresholds and outputs were lower in endocardial than in epicardial pacing. A false negative capture detection occurred during the "acute phase" in 3 patients (6.0%), with incorrect automatic output increase to 5 V/1 ms. After this phase, the problem was still detected in 2 patients (4.0%). VCM correctly identified threshold increases in 2 patients (1%). No pacing defect was documented. VCM was not performed in 4 infants (8.0%) for pacing rate ≥ 100 b/min. Conclusions: VCM function is safe and effective in reducing pacing output in pediatric patients; this may increase PM longevity. Epicardial pacing shows higher thresholds and outputs than endocardial pacing.
AB - Background: The Ventricular Capture ManagementTM (VCM) of Medtronic Kappa 700 series pacemakers (PM) performs automatic threshold detection and optimization of pacing output that may enhance generator longevity. We evaluated efficacy and safety of this algorithm in children. Methods. The study was prospective, non-randomized, involving 50 consecutive patients (mean age 5.6 ± 6.6 years, median 4 years), enrolled at first PM implant. VCM was active from the implant, with nominal values of safety margin, minimum adapted pulse amplitude and width. Leads were endocardial and epicardial, all unipolar. Thresholds and pacing outputs were registered with telemetric PM interrogation. Endocardial and epicardial thresholds and outputs were also compared. Follow-up duration was 27 ± 13 months (range 6-49 months). Results: A significant reduction in pulse amplitude was evident since the sixth month. Thresholds and outputs were lower in endocardial than in epicardial pacing. A false negative capture detection occurred during the "acute phase" in 3 patients (6.0%), with incorrect automatic output increase to 5 V/1 ms. After this phase, the problem was still detected in 2 patients (4.0%). VCM correctly identified threshold increases in 2 patients (1%). No pacing defect was documented. VCM was not performed in 4 infants (8.0%) for pacing rate ≥ 100 b/min. Conclusions: VCM function is safe and effective in reducing pacing output in pediatric patients; this may increase PM longevity. Epicardial pacing shows higher thresholds and outputs than endocardial pacing.
KW - Cardiac pacing
KW - Circadian variation
KW - Pacemaker
KW - Pediatric age
UR - http://www.scopus.com/inward/record.url?scp=33744751234&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33744751234&partnerID=8YFLogxK
M3 - Article
C2 - 16212078
AN - SCOPUS:33744751234
VL - 6
SP - 751
EP - 756
JO - Italian Heart Journal
JF - Italian Heart Journal
SN - 1129-471X
IS - 9
ER -